Literature DB >> 31676142

Late-onset Pompe disease associated with polyneuropathy.

M Lamartine S Monteiro1, G Remiche2.   

Abstract

Late-onset Pompe disease is caused by a glycogen deposition involving mainly striated muscle. It may also target many other tissues such as liver, smooth muscles or spine anterior horn. Glycogen accumulation in Schwann cells and in the perineurium of peripheral nerves was shown in Pompe's disease mouse models. Moreover two late-onset Pompe disease patients were reported as having a small fiber neuropathy. To the best of our knowledge an involvement of large nerve fibers was never depicted. We describe four late-onset Pompe disease patients having a concomitant polyneuropathy of undetermined etiology. Our observations reinforce the proof-of-concept supporting a potential involvement of peripheral nerves as additional organ targeted by late-onset Pompe disease. It has clinical care consequences since peripheral neuropathy in late-onset Pompe disease could worsen patient's disability and needs particular care such as proprioceptive physiotherapy.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Late-onset Pompe disease; Polyneuropathy

Mesh:

Year:  2019        PMID: 31676142     DOI: 10.1016/j.nmd.2019.08.016

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  3 in total

1.  Small fiber involvement is independent from clinical pain in late-onset Pompe disease.

Authors:  Elena K Enax-Krumova; Iris Dahlhaus; Jonas Görlach; Kristl G Claeys; Federica Montagnese; Llka Schneider; Dietrich Sturm; Tanja Fangerau; Hannah Schlierbach; Angela Roth; Julia V Wanschitz; Wolfgang N Löscher; Anne-Katrin Güttsches; Stefan Vielhaber; Rebecca Hasseli; Lea Zunk; Heidrun H Krämer; Andreas Hahn; Benedikt Schoser; Angela Rosenbohm; Anne Schänzer
Journal:  Orphanet J Rare Dis       Date:  2022-04-27       Impact factor: 4.303

2.  Diagnostic Challenges in Late Onset Multiple Acyl-CoA Dehydrogenase Deficiency: Clinical, Morphological, and Genetic Aspects.

Authors:  Antonino Lupica; Rosaria Oteri; Sara Volta; Daniele Ghezzi; Selene Francesca Anna Drago; Carmelo Rodolico; Olimpia Musumeci; Antonio Toscano
Journal:  Front Neurol       Date:  2022-03-03       Impact factor: 4.003

3.  Late-onset Pompe disease (LOPD) in Belgium: clinical characteristics and outcome measures.

Authors:  P Vanherpe; S Fieuws; A D'Hondt; C Bleyenheuft; P Demaerel; J De Bleecker; P Van den Bergh; J Baets; G Remiche; K Verhoeven; S Delstanche; M Toussaint; B Buyse; P Van Damme; C E Depuydt; K G Claeys
Journal:  Orphanet J Rare Dis       Date:  2020-04-05       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.